Literature DB >> 18267181

Lung cancer screening with CT.

Denise R Aberle1, Kathleen Brown.   

Abstract

Lung cancer is the leading cause of cancer death in the United States. Non-small cell lung cancer accounts for 75% to 80% of all lung cancers. There is an impetus to find a screening test that can detect non-small cell lung cancer in its early preclinical stages, when surgical resection is most likely to reduce lung cancer mortality. Although earlier randomized controlled trials of lung cancer screening using chest radiography and sputum cytology failed to show reduced lung cancer mortality, CT is a much more sensitive test for detecting small lung nodules, and has generated considerable enthusiasm as a potential contemporary screening tool for lung cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18267181      PMCID: PMC4307918          DOI: 10.1016/j.ccm.2007.12.001

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  61 in total

1.  Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.

Authors:  Rebecca M Lindell; Thomas E Hartman; Stephen J Swensen; James R Jett; David E Midthun; Henry D Tazelaar; Jayawant N Mandrekar
Journal:  Radiology       Date:  2007-02       Impact factor: 11.105

Review 2.  Biomarkers for lung cancer: clinical uses.

Authors:  Alissa K Greenberg; M Sung Lee
Journal:  Curr Opin Pulm Med       Date:  2007-07       Impact factor: 3.155

Review 3.  Epidemiology of lung cancer.

Authors:  R A Smith; T J Glynn
Journal:  Radiol Clin North Am       Date:  2000-05       Impact factor: 2.303

4.  Validation of a model of lung cancer risk prediction among smokers.

Authors:  Kathleen A Cronin; Mitchell H Gail; Zhaohui Zou; Peter B Bach; Jarmo Virtamo; Demetrius Albanes
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

5.  The natural course of preneoplastic lesions in bronchial epithelium.

Authors:  Roderick H Breuer; Arifa Pasic; Egbert F Smit; Esther van Vliet; Anton Vonk Noordegraaf; Elle J Risse; Pieter E Postmus; Thomas G Sutedja
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

6.  Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography.

Authors:  M Kaneko; K Eguchi; H Ohmatsu; R Kakinuma; T Naruke; K Suemasu; N Moriyama
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

7.  Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.

Authors:  Stefan Diederich; Michael Thomas; Michael Semik; Horst Lenzen; Nikolaus Roos; Anushe Weber; Walter Heindel; Dag Wormanns
Journal:  Eur Radiol       Date:  2004-01-16       Impact factor: 5.315

8.  The effect of tumor size on curability of stage I non-small cell lung cancers.

Authors:  Juan P Wisnivesky; David Yankelevitz; Claudia I Henschke
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Authors:  Thierry Blanchon; Jeanne-Marie Bréchot; Philippe A Grenier; Gilbert R Ferretti; Etienne Lemarié; Bernard Milleron; Dominique Chagué; François Laurent; Yves Martinet; Catherine Beigelman-Aubry; François Blanchon; Marie-Pierre Revel; Sylvie Friard; Martine Rémy-Jardin; Manuela Vasile; Nicola Santelmo; Alain Lecalier; Patricia Lefébure; Denis Moro-Sibilot; Jean-Luc Breton; Marie-France Carette; Christian Brambilla; François Fournel; Alexia Kieffer; Guy Frija; Antoine Flahault
Journal:  Lung Cancer       Date:  2007-07-12       Impact factor: 5.705

Review 10.  Overdiagnosis and overtreatment of early detected prostate cancer.

Authors:  C H Bangma; S Roemeling; F H Schröder
Journal:  World J Urol       Date:  2007-02-14       Impact factor: 4.226

View more
  7 in total

1.  Size of solitary pulmonary nodule was the risk factor of malignancy.

Authors:  Chang-Zheng Shi; Qian Zhao; Liang-Ping Luo; Jian-Xing He
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

2.  Lung cancer screening: from imaging to biomarker.

Authors:  Dong Xiang; Bicheng Zhang; Donald Doll; Kui Shen; Goetz Kloecker; Carl Freter
Journal:  Biomark Res       Date:  2013-01-16

3.  Magnetic resonance imaging for lung cancer detection: experience in a population of more than 10,000 healthy individuals.

Authors:  Nai-Yuan Wu; Hui-Cheng Cheng; James S Ko; Yu-Chen Cheng; Po-Wei Lin; Wei-Chan Lin; Cheng-Yen Chang; Der-Ming Liou
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

Review 4.  Small peripheral lung adenocarcinoma: CT and histopathologic characteristics and prognostic implications.

Authors:  Zhi-gang Chu; Zhi-gang Yang; Heng Shao; Zhi-yu Zhu; Wen Deng; Shi-si Tang; Jing Chen; Yuan Li
Journal:  Cancer Imaging       Date:  2011-12-28       Impact factor: 3.909

5.  Effects of Bevacizumab Combined with Chemotherapy on CT, CyFRA21-1, and ProGRP and Prognosis of Lung Cancer Patients under Nursing Intervention.

Authors:  Chao Xi; Hong Jiang; Yinling Xue; Yongmei Lv; Chao Wang
Journal:  Comput Math Methods Med       Date:  2022-07-14       Impact factor: 2.809

Review 6.  Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.

Authors:  Francesca Moretti; Paola D'Antona; Emanuele Finardi; Marco Barbetta; Lorenzo Dominioni; Albino Poli; Elisabetta Gini; Douglas M Noonan; Andrea Imperatori; Nicola Rotolo; Maria Cattoni; Paola Campomenosi
Journal:  Oncotarget       Date:  2017-10-11

Review 7.  Screening and Biosensor-Based Approaches for Lung Cancer Detection.

Authors:  Lulu Wang
Journal:  Sensors (Basel)       Date:  2017-10-23       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.